share_log

Marijuana Breathalyzers: Cannabix Technologies Correlates THC In Breath & Blood In New Experimental Study

Benzinga Real-time News ·  May 9, 2022 10:50

Cannabix Technologies Inc. (CSE:BLO) (OTC:BLOZF) reported that it has successfully tested a supplemental version of its FAIMS technology for the detection of delta9-tetrahydrocannabinol (THC) and related analytes in human breath in an independent experimental study. The study showed a correlation between breath samples collected and analyzed with Cannabix hardware and blood plasma levels of THC. The company's handheld Breath Collection Unit and newly developed laboratory MS Breath Sampler were used together to provide a new ground-breaking method for drug detection. Cannabix has developed a unique breath analysis system capable of sampling breath for low volatility analytes

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment